Stephane Bancel

Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
Steve Weiss Once Predicted Moderna Stock Would Rise 500% And Trade Like Amazon: Now He's Selling As The CEO Dumps Shares
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
Steve Weiss Once Predicted Moderna Stock Would Rise 500% And Trade Like Amazon: Now He's Selling As The CEO Dumps Shares
Time 100 Most Influential List Includes 10 Connected To Public Companies Such As Tim Cook, Andy Jassy And Joe Rogan
Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know

Stephane Bancel Recent News

Why Moderna Shares Are Rising Today
Moderna Inc (NASDAQ: MRNA) is trading higher Monday morning after the company announced preliminary booster data. 
What's Going On With Moderna Shares Today?
Moderna Inc (NASDAQ: MRNA) is trading lower Friday after the company announced interim Phase 1 data for its mRNA flu vaccine.
Why Moderna Shares Are Rising Today
Moderna Inc (NASDAQ: MRNA) is trading higher Monday amid increasing concerns surrounding the omicron COVID-19 variant. 
Moderna CEO Weighs In On Omicron Variant: We Believe It's 'Already Present In Most Countries'
Global markets fell sharply Friday amid increasing fears about a new COVID-19 variant, omicron.
Why Moderna Shares Continue To Climb Higher Today
Moderna Inc (NASDAQ: MRNA) is trading higher on continued strength Monday after the U.S. Food and Drug Administration last week authorized booster doses of the company's COVID-19 vaccine in the US for adults 18 and older.
Why Moderna Shares Are Trading Higher Today
Moderna Inc (NASDAQ: MRNA) is trading higher Friday after the company announced the U.S. Food and Drug Administration authorized its booster dose of COVID-19 vaccine in the U.S. for adults 18 and older.
Why Moderna's Stock Is Moving Higher Today
Moderna Inc (NASDAQ: MRNA) is trading higher Wednesday after the company filed for authorization of its COVID-19 vaccine, a 50 microgram two-dose series of SPIKEVAX, with Health Canada to include children ages six to 11.
Why Moderna Shares Are Rising
Moderna Inc (NASDAQ: MRNA) is trading higher Friday after the company announced the FDA Advisory Committee unanimously voted in support of Emergency Use for a booster dose of the company's COVID-19 vaccine in the US.
Chief Executive Officer Of Moderna Makes $7.3M Sale
Stephane Bancel, Chief Executive Officer at Moderna (NASDAQ:MRNA), made a large insider sell on September 30, according to a new SEC filing.
Notable Moderna Insider Makes $8.20 Million Sale
Stephane Bancel, Chief Executive Officer at Moderna (NASDAQ:MRNA), made a large insider sell on September 9, according to a new SEC filing.
What's Going On With Moderna's Stock Today?
Moderna Inc (NASDAQ: MRNA) is trading higher Monday as growing COVID-19 concerns lift vaccine makers. The company's COVID-19 vaccine was also granted provisional registration by the Australian Therapeutic Goods Administration.
What's Going On With Moderna's Stock Today?
Moderna Inc (NASDAQ: MRNA) is trading higher Wednesday on continued strength following the company's announcement that it received FDA Fast Track designation for mRNA-1345.
Moderna Hires Ogilvy Health CEO Kate Cronin As Chief Brand Officer To Build On COVID-19 Vaccine Momentum
COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA) announced Monday a new hire to enhance its brand appeal.
11 Biopharma CEOs To Follow On Twitter

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved